Inventor
XINDE XU
Inventor
CN
Overview
Patents· 4 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A23Lprimary
A23LFoods, foodstuffs or non-alcoholic beverages, not otherwise provided for13%
A23PShaping or working of foodstuffs, not fully covered by a single other subclass13%
A61KPreparations for medical, dental or toiletry purposes13%
C07CAcyclic or carbocyclic compounds13%
A23VIndexing scheme relating to foods, foodstuffs or non-alcoholic beverages and lactic or propionic acid bacteria used in foodstuffs or food preparation6%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations6%
B02CCrushing, pulverising, or disintegrating in general6%
C07BGeneral methods of organic chemistry6%
C11BProducing, e.g. by pressing raw materials or by extraction from waste materials, refining or preserving fats, fatty substances, e.g. lanolin, fatty oils or waxes6%
C11CFatty acids from fats, oils or waxes6%
PatentTitleYear
12,302,931Solid beverage containing barley leaves and preparation method thereof202512,239,613Preparation method for carotenoid preparation having high bioavailability and high stability202511,920,175Method for extracting and isolating lutein crystal from vegetable oil resin containing lutein diester202411,180,445Method for recycling urea in urea adduct process2021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021–2025Patents assigned to ZHEJIANG MED XINCHANG PHARM (4)· patent assignee history
2021Patents assigned to ZHEJANG MEDICINE CO LTD XINCHANG PHARMACEUTICAL FACTORY (1)· patent assignee history
2021–2025Based in CN· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| ZHEJIANG MED XINCHANG PHARM | 4 | 2021–2025 |
| ZHEJANG MEDICINE CO LTD XINCHANG PHARMACEUTICAL FACTORY | 1 | 2021 |
Locations
| Location | Patents | Span |
|---|---|---|
| CN | 4 | 2021–2025 |